Johnson B W, Chambers T V, Crabtree M B, Arroyo J, Monath T P, Miller B R
Division of Vector-Borne Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado 80521, USA.
Med Vet Entomol. 2003 Sep;17(3):235-43. doi: 10.1046/j.1365-2915.2003.00438.x.
In 1999 West Nile (WN) virus was introduced to North America where this flavivirus has spread rapidly among wildlife (especially birds) transmitted by various species of mosquitoes (Diptera: Culicidae). Increasing numbers of cases and deaths among humans, horses and other domestic animals require development of effective vaccines. 'ChimeriVax-West Nile(vet)' is being developed for use as a veterinary vaccine to protect against WN infection. This chimeric virus contains the pre-membrane (prM) and envelope (E) genes from the wild-type WN NY99 virus (isolated from a flamingo in New York zoo during the 1999 WN epidemic) in the backbone of yellow fever (YF) 17D vaccine virus. Replication kinetics of ChimeriVax-WN(vet) virus were evaluated in mosquito cell culture (Aedes albopictus C6/36), in WN vector mosquitoes [Culex tritaeniorhynchus Giles, Cx. nigripalpus Theobald and Cx. quinquefasciatus Say (Diptera: Culicidae)] and in YF vectors [Aedes aegypti (L) and Ae. albopictus (Skuse)], to determine whether these mosquitoes become infected through feeding on a viraemic vaccine, and their potential infectivity to transmit the virus. Growth of ChimeriVax-WN(vet) virus was found to be restricted in mosquitoes, compared to WN virus in Ae. albopictus C6/36 cells. When inoculated intrathoracically, ChimeriVax-WN(vet) and YF 17D viruses did not replicate in Cx. tritaeniorhynchus or Cx. nigripalpus; replication was very restricted compared to the wild-type WN virus in Cx. quinquefasciatus, Ae. aegypti and Ae. albopictus. When fed on hanging drops with ChimeriVax-WN(vet) virus (7.7 log10 PFU/mL), none of the Culex mosquitoes became infected; one Ae. albopictus and 10% of the Ae. aegypti became infected, but the titre was very low and virus did not disseminate to head tissue. ChimeriVax-WN(vet) virus had a replication profile similar to that of the attenuated vaccine virus YF 17D, which is not transmitted by mosquitoes. These results suggest that the natural mosquito vectors of WN and YF viruses, which may incidentally take a bloodmeal from a vaccinated host, will not become infected with ChimeriVax-WN(vet) virus.
1999年,西尼罗河(WN)病毒传入北美,这种黄病毒在由各种蚊子(双翅目:蚊科)传播的野生动物(尤其是鸟类)中迅速传播。人类、马匹和其他家畜中病例和死亡人数不断增加,需要研发有效的疫苗。“嵌合西尼罗河疫苗(兽用)”正在研发中,用作兽用疫苗以预防WN感染。这种嵌合病毒在黄热病(YF)17D疫苗病毒的主干中,包含野生型WN NY99病毒(1999年WN疫情期间从纽约动物园一只火烈鸟身上分离)的前膜(prM)和包膜(E)基因。在蚊细胞培养物(白纹伊蚊C6/36)、WN媒介蚊子[三带喙库蚊Giles、黑胸库蚊Theobald和致倦库蚊Say(双翅目:蚊科)]以及YF媒介[埃及伊蚊(L)和白纹伊蚊(Skuse)]中评估了嵌合西尼罗河疫苗(兽用)病毒的复制动力学,以确定这些蚊子是否通过吸食含病毒血症的疫苗而被感染,以及它们传播病毒的潜在传染性。与白纹伊蚊C6/36细胞中的WN病毒相比,发现嵌合西尼罗河疫苗(兽用)病毒在蚊子中的生长受到限制。当经胸接种时,嵌合西尼罗河疫苗(兽用)和YF 17D病毒在三带喙库蚊或黑胸库蚊中不复制;与致倦库蚊、埃及伊蚊和白纹伊蚊中的野生型WN病毒相比,复制受到极大限制。当用嵌合西尼罗河疫苗(兽用)病毒(7.7 log10 PFU/mL)通过悬滴法喂食时,没有一只库蚊被感染;一只白纹伊蚊和10%的埃及伊蚊被感染,但滴度非常低,且病毒未传播到头组织。嵌合西尼罗河疫苗(兽用)病毒的复制情况与减毒疫苗病毒YF 17D相似,后者不会通过蚊子传播。这些结果表明,WN和YF病毒的天然蚊子媒介可能偶然从接种疫苗的宿主身上吸食血液,但不会感染嵌合西尼罗河疫苗(兽用)病毒。